FinnCap reiterated their corporate rating on shares of OptiBiotix Health PLC (LON:OPTI) in a report published on Wednesday morning.

Shares of OptiBiotix Health PLC (OPTI) opened at GBX 76 ($1.00) on Wednesday. OptiBiotix Health PLC has a 52 week low of GBX 59 ($0.78) and a 52 week high of GBX 90 ($1.19).

COPYRIGHT VIOLATION NOTICE: “OptiBiotix Health PLC (OPTI) Given “Corporate” Rating at FinnCap” was reported by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at

About OptiBiotix Health PLC

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.